ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

The IL6/Th17 Pathway May Play Different Roles in Cell-Mediated and Antibody-Mediated Alloimmune Injury in Renal Allografts.

D. Dobi,1 Q. Tang,2 S. Chandran,3 F. Vincenti,3 Z. Laszik.1

1Department of Pathology, University of California, San Francisco, San Francisco, CA
2Department of Surgery, Division of Transplant Surgery, University of California, San Francisco, San Francisco, CA
3Department of Medicine, Division of Nephrology, University of California, San Francisco, San Francisco, CA

Meeting: 2017 American Transplant Congress

Abstract number: D125

Keywords: Kidney, Rejection

Session Information

Session Name: Poster Session D: Kidney: Acute Cellular Rejection

Session Type: Poster Session

Date: Tuesday, May 2, 2017

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall D1

Purpose. IL6 has been shown to contribute to shifting the balance between tolerogenic regulatory T cells and proinflammatory Th17 cells towards the latter. Our study explores the differences between the expression patterns of IL6 (a master initiator of Th17 differentiation) and other Th17 signature genes across the Banff diagnostic categories of Normal, Borderline changes (BL), Acute cellular rejection (ACR), and Acute Antibody-mediated rejection (aAMR).

Material and Methods. 12 patients were enrolled from each diagnostic group. Gene expression analysis was performed on formalin-fixed paraffin-embedded tissues with the NanoString nCounter platform using a customized panel of 800 genes. Multivariate regression analysis was carried out to compare log2 transformed gene-expression levels of BL, ACR, and aAMR groups to the baseline of Normal. Cell abundance scores were created by using the average of log2 transformed expression levels of genes specific to a given cell-type.

Results. While ACR and aAMR cases showed increased expression of IL6 compared to Normal cases (Table 1), BL group did not. Gene expression level of IL17-F was increased significantly only in aAMR compared to Normal (Table 1).

mRNA Log2 fold change Lower confidence limit Upper confidence limit corrected p-value
IL6 (aAMR vs. Normal) 2.48 1.51 3.44 <0.0005
IL6 (ACR vs. Normal) 2.00 1.06 2.94 <0.0005
IL17-F (aAMR vs. Normal) 1.09 0.477 1.71 0.0021

Th17 abundance score (Th17AS) was significantly different amongst different diagnostic groups (p<0.0005). Th17AS increased from the Normal group (4.37±0.38) to the BL (4.83±0.57), aAMR (5.98±0.54), and ACR (6.08±0.71) groups.

Conclusions. While signature genes reveal activation of the IL6/Th17 axis in both ACR and aAMR, only aAMR cases showed increased expression of IL17-F, one of the hallmark cytokines of the Th17 lineage. This may indicate a different role of IL6/Th17 pathway in aAMR relative to ACR. Biologic heterogeneity within the BL group might account for the lack of statistical separation of this group from the Normal cases.

CITATION INFORMATION: Dobi D, Tang Q, Chandran S, Vincenti F, Laszik Z. The IL6/Th17 Pathway May Play Different Roles in Cell-Mediated and Antibody-Mediated Alloimmune Injury in Renal Allografts. Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Dobi D, Tang Q, Chandran S, Vincenti F, Laszik Z. The IL6/Th17 Pathway May Play Different Roles in Cell-Mediated and Antibody-Mediated Alloimmune Injury in Renal Allografts. [abstract]. Am J Transplant. 2017; 17 (suppl 3). https://atcmeetingabstracts.com/abstract/the-il6th17-pathway-may-play-different-roles-in-cell-mediated-and-antibody-mediated-alloimmune-injury-in-renal-allografts/. Accessed May 10, 2025.

« Back to 2017 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences